Knight Therapeutics Inc. (TSX: GUD) (“Knight”), a pan-American (ex-USA) specialty pharmaceutical company, and Helsinn Healthcare SA (“Helsinn”), a global pharmaceutical ...
In light of this decline, the recent rebound from 0.6131 to last Friday's high of 0.6330 appears more corrective than ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback